GUGGENHEIM CAPITAL LLC - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 78 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$91,000
+11.0%
49,561
+27.9%
0.00%
Q4 2017$82,000
-13.7%
38,749
-9.3%
0.00%
Q3 2017$95,000
+75.9%
42,712
+35.1%
0.00%
Q2 2017$54,000
-30.8%
31,621
-0.2%
0.00%
Q1 2017$78,000
+66.0%
31,691
+0.0%
0.00%
Q4 2016$47,000
-41.2%
31,689
+1.9%
0.00%
Q3 2016$80,000
+70.2%
31,092
-0.2%
0.00%
Q2 2016$47,000
-21.7%
31,151
+3.2%
0.00%
Q1 2016$60,000
-23.1%
30,182
+19.5%
0.00%
Q4 2015$78,000
-7.1%
25,265
+0.9%
0.00%
Q3 2015$84,000
-12.5%
25,044
-2.8%
0.00%
Q2 2015$96,000
+3.2%
25,766
+3.0%
0.00%
Q1 2015$93,000
+17.7%
25,014
+40.8%
0.00%
Q4 2014$79,000
+125.7%
17,761
+14.1%
0.00%
Q3 2014$35,000
-66.0%
15,572
-56.1%
0.00%
Q2 2014$103,000
-17.6%
35,461
+15.6%
0.00%
Q1 2014$125,000
+52.4%
30,673
+72.9%
0.00%
Q4 2013$82,000
+310.0%
17,743
+56.4%
0.00%
Q3 2013$20,00011,3430.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Broadfin Capital, LLC 4,525,000$7,874,0001.40%
DAFNA Capital Management LLC 200,000$348,0000.38%
HealthCor Management, L.P. 3,270,000$5,690,0000.30%
Baker Brothers Advisors 5,865,000$10,205,0000.14%
Spark Investment Management LLC 152,500$262,0000.06%
NATIXIS 3,148,916$5,479,0000.06%
GUARDIAN LIFE INSURANCE CO OF AMERICA 371,759$647,0000.05%
LEAVELL INVESTMENT MANAGEMENT, INC. 81,271$141,0000.02%
TFS CAPITAL LLC 118,232$206,0000.01%
First Eagle Investment Management, LLC 1,434,296$2,496,0000.01%
View complete list of IDERA PHARMACEUTICALS INC shareholders